Skye Bioscience Inc.’s Post

Skye Bioscience Inc. reposted this

View organization page for Nasdaq, graphic

489,117 followers

“Our mission at Skye is very simple. We’re absolutely interested in developing precision therapeutics and pharmaceuticals that help patients.” Skye Bioscience Inc. CEO Punit Dhillon reflects on the clinical-stage biotechnology company’s mission and how being #NasdaqListed helps them to deliver on that mission.

Jay Yanelli

GitLab | Continuous Collaboration ♾️

5mo

I’m never negative on LinkedIn or in general. But this has to be said. Every company Punit Dhillon or the Dhillons have done this with has filed bankruptcy in one form or another. Punit has walked away from the companies to rinse and repeat with the next. This is decades of the same nonsense and it will repeat here at Skye.

Like
Reply

Hi Dear India offers a big opportunity for Glaucoma and Metabolic disorder obesity being rampant. Any interest to make your presence in India, I am available to make it a grand success having invested over four decades in the industry as profit centre head. Best Wishes

Julie Kampf

CEO JBK Associates International Public Company Board Director New York Metro Area, Florida, North Carolina.

5mo

Fabulous Punit!

Mark Doscher

Principal at Marsh & McLennan Agency - West

5mo

Congrats buddy!!

See more comments

To view or add a comment, sign in

Explore topics